//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 01 October, 2020, 05:24 PM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Strides Pharma Science Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 01 Oct, 2020, 03:59 PM IST
    725.15

    Today's Change

    5.60 (0.78%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    883,497

    Open

    724.80

    Prev. Close

    719.55

    Day's Trend

    Low
    718.35
    High
    737.00
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)10.00
    • EPS-TTM (Rs.)15.21
    • BV/share (₹)289.69
    • 52Wk L/H268.00/ 755.00
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News
    Buy Strides Pharma, target price Rs 495: Motilal Oswal| Recos
    Buy
    Hold Strides Pharma, target price Rs 357: Geojit| Recos
    Hold
    Sell Strides Pharma, target Rs 375: Manas Jaiswal| Recos
    Sell
    Strides Pharma Science Ltd.Intimation Under Regulation 31A Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requiremen...| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Strides Pharma Science Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011q| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011| Announcement
    Strides Pharma Science Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Strides Pharma Science Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Strides Pharma Science Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Strides Pharma Science Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Strides Pharma Science Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Strides Pharma Science Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Strides Pharma Science Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Strides inks JV pact with China's Sihuan Pharma| News

    Strides Pharma Science Ltd. Share Price Updates

    Strides Pharma Science Ltd. share price up by 0.78% from its previous close of Rs 719.55. Strides Pharma Science Ltd. stock last traded price is 725.15
    Strides Pharma Science Ltd. Share Price
    Value
    Today/Current/Last
    725.15
    Previous Day
    719.55
    What's your view on Strides Pharma Science for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Strides Pharma Science Ltd.

    Strides Pharma Science Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    781.80
    26.37
    14.00
    0.00
    7585.25
    Other Operating Income
    0.00
    0.00
    0.00
    -0.72
    118.06
    Operating Profit
    154.90
    138.17
    28.10
    -14.20
    2526.83
    Other Income
    12.30
    -30.28
    20.05
    0.00
    153.79
    EBITDA
    167.21
    102.21
    27.48
    -14.20
    2526.83
    Interest
    36.91
    -8.48
    4.44
    0.00
    102.00
    Depreciation
    49.13
    8.36
    14.55
    0.00
    495.92
    Tax
    3.28
    NA
    5.22
    -110.66
    305.90
    Net Profit
    103.56
    NA
    2699.03
    -1655.60
    780.58
    EPS (₹)
    11.56
    NA
    2719.51
    -10.81
    68.30

    Strides Pharma Science Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    725.15
    0.78
    13.07
    22.96
    77.08
    134.64
    -18.11
    -41.24
    302.85
    2.80
    13.05
    1.80
    8.14
    18.46
    -50.78
    -80.14
    172.50
    -0.69
    3.95
    -2.62
    8.25
    44.35
    -54.63
    -55.17
    163.60
    4.27
    12.59
    -2.27
    29.38
    -0.12
    -51.55
    0.00
    396.20
    4.24
    7.27
    17.12
    64.45
    0.00
    0.00
    0.00
    156.05
    1.53
    9.39
    22.15
    61.46
    114.80
    32.87
    0.00
    558.30
    -0.23
    1.18
    8.83
    19.42
    106.09
    -4.94
    19.81
    348.95
    -2.02
    6.94
    15.39
    26.82
    105.26
    87.00
    44.91
    556.45
    0.51
    3.34
    10.55
    60.59
    33.01
    -19.45
    92.88
    809.85
    5.00
    14.90
    16.34
    153.82
    611.02
    521.10
    434.03
    727.10
    0.15
    0.62
    -6.00
    46.80
    309.63
    1408.51
    782.40
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Strides Pharma Science Ltd Risk Return Comparison

    with peersNew

    Strides Pharma Science Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Strides Pharma Science Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    1.44
    7.15
    -97.73
    37.52
    Return on Assets (%)
    0.65
    5.06
    -34.68
    37.98
    Return on capital Employed (%)
    8.16
    9.13
    -13.51
    32.77
    Fixed Assets Turnover (x)
    0.53
    0.41
    -36.70
    3.05
    Profitability and Growth
    Gross Profit Margin (%)
    12.43
    8.10
    -100.49
    43.32
    Operating Profit Margin(%)
    18.74
    14.28
    -46.07
    46.18
    Net Profit margin (%)
    1.32
    -0.11
    -357.87
    38.01
    Financial Strength
    Liquidity
    Quick Ratio (x)
    1.22
    1.98
    0.08
    37.52
    Current Ratio (x)
    1.79
    2.76
    0.21
    37.52
    Cash ratio (x)
    0.14
    0.24
    0.00
    2.43
    Solvency
    Debt Equity Ratio (x)
    0.24
    0.23
    0.00
    3.08
    Coverage Ratios
    Cash flows to long term debt (x)
    4.56
    2.79
    0.00
    24.88
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Strides Pharma Science Ltd Share Holding as on 30-06-2020

    CategoryNo. of sharesPercentage
    Promoters26,610,07129.71
    ForeignInstitutions23,989,99026.78
    NBanksMutualFunds14,007,22415.64
    Others8,286,1709.25
    GeneralPublic13,310,74514.86
    FinancialInstitutions3,363,4643.76

    MF Ownership Of Strides Pharma Science Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    Aditya Birla SL Equity Direct-G
    Portfolio as on 31-08-2020
    Equity: Multi Cap
    3003131
    -5.67%
    1.65%
    181.43
    SBI Bluechip Direct-G
    Portfolio as on 31-08-2020
    Equity: Large Cap
    2069863
    0.00%
    0.55%
    125.05
    SBI Long Term Equity Fund Direct-G
    Portfolio as on 31-08-2020
    Equity: ELSS
    1840000
    0.00%
    1.5%
    111.16
    SBI Magnum Midcap Direct-G
    Portfolio as on 31-08-2020
    Equity: Mid Cap
    1338241
    0.00%
    2.25%
    80.85
    HDFC Mid-Cap Opportunities Direct-G
    Portfolio as on 31-08-2020
    Equity: Mid Cap
    1122216
    0.00%
    0.31%
    67.80

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Strides Pharma Science Ltd.

    Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 6495.00 Crore) operating in Pharmaceuticals sector.

    Strides Pharma Science Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1524.27 Crore to Sales Value (91.04 % of Total Sales), Other Operating Revenue which contributed Rs 82.52 Crore to Sales Value (4.92 % of Total Sales), Export Incentives which contributed Rs 33.12 Crore to Sales Value (1.97 % of Total Sales), Royalty Income which contributed Rs 24.73 Crore to Sales Value (1.47 % of Total Sales) and Sale of services which contributed Rs 9.51 Crore to Sales Value (0.56 % of Total Sales)for the year ending 31-Mar-2020.

    For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 781.80 Crore, up 26.37 % from last quarter Sales of Rs 618.64 Crore and up 14.00 % from last year same quarter Sales of Rs 685.80 Crore Company has reported net profit after tax of Rs 122.80 Crore in latest quarter.

    The company’s top management includes Dr.Kausalya Santhanam, Dr.R Ananthanarayanan, Mr.Arun Kumar, Mr.Badree Komandur, Mr.Bharat D Shah, Mr.Deepak Vaidya, Mr.Homi Rustam Khusrokhan, Mr.S Sridhar, Ms.Sangita Reddy. Company has BSR & Co. LLP as its auditors As on 30-06-2020, the company has a total of 89,567,664 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors